Supreme Pharmaceuticals Inc. Changes Name to The Supreme Cannabis Company, Inc. and Announces Conversion of Approximately $17.4 Million Aggregate Principal Amount of 10% Unsecured Convertible Debentures Due 2019
Supreme Pharmaceuticals Closes $40.25 Million Bought Deal Private Placement of Convertible Debenture Units
